Phospho-NF-κB p65 (Ser536) antibody | knockout validation | Cell Signaling 3033

This is a knockout-validated antibody summary, based on the publication "A NIK-SIX Signalling Axis Controls Inflammation by Targeted Silencing of Non-Canonical NF-κB", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: Phospho-NF-κB p65 (Ser536)

Catalog number: 3033

Summary: Rabbit monoclonal IgG against a synthetic phosphopeptide corresponding to residues surrounding Ser536 of human NF-κB p65. Reacts with human, mouse, rat, hamster, monkey, and pig. It is predicted to react based on 100% sequence homology with dog. Suitable for western blot, immunoprecipitation, immunofluorescence/immunocytochemistry and flow cytometry.

Validation Method

Western blot

Sample

WT, RelA−/− or RelB−/− fibroblasts.

Figure

Western blot shows endogenous RelA and RelB expression in parental and RelA−/− or RelB−/− fibroblasts and response to stimulation by 24-hour application of TWEAK. Please see Extended Data Fig. 5b in the article [1].

References
  1. Liu Z, Mar K, Hanners N, Perelman S, Kanchwala M, Xing C, et al. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB. Nature. 2019;: pubmed publisher